About Penn Blood Disorder Center
"CORONAVIRUS INFO: Penn Medicine is dedicated to the health and safety of patients, their families, and our staff. Please visit our website for COVID-19 updates, including coronavirus FAQs, our visitation policy, and drive-thru testing."
Clinical Trials at Penn Blood Disorder Center
During the past decade, Penn Blood Disorder Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Penn Blood Disorder Center
According to Clinical.Site data, the most researched conditions in "Penn Blood Disorder Center" are
"Hemophilia B" (2 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Penn Blood Disorder Center" in a lesser frequency.
Clinical Trials Intervention Types at Penn Blood Disorder Center
Most popular intervention types in "Penn Blood Disorder Center" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "PF-06838435/ fidanacogene elaparvovec" (1 trials), "Standard of Care FIX Replacement therapy" (1 trials) and "Standard of Care FVIII Replacement therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Penn Blood Disorder Center
The vast majority of trials in "Penn Blood Disorder Center" are
2 trials for "Male" genders.
Clinical Trials Status at Penn Blood Disorder Center
Currently, there are NaN active trials in "Penn Blood Disorder Center".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Penn Blood Disorder Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Penn Blood Disorder Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".